Cytek Biosciences, Inc.

US$5.83As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CTKBHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (22.38%)
Div yield —
ROE (23.20%)
Medical Devices
Beta (5Y) 1.14
PE TTM —
TSR TTM 49.49%
Mkt cap US$762.5M
ROIC (52.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.12
22.11%
(11.72%)
Hold 6|10|9|6|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.07
0.07
1.46%
2.91%
16.37%
15.88%
Revenue$M
75.07
77.82
75.50
75.20
10.65%
11.99%
4.44%
(0.27%)
Peers (US$762.5M)
Cap (US$)
PE
761.9M
22.10x
Capital
TTM
5Y
10Y
Leveragex
1.813
0.200
0.197
EBIT/Intx
1.378
0.138
0.102
Own earn%
(129.21)
(45.85)
(48.01)
Sh yield%
24.85
70.99
65.82
Owners
Insiders/Inst%
11.87
20.87
Short interest%
2.31
SBC / revenue%
0.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
18–22
$1 testx
—
Incr. ROIC%
3